SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-023848
Filing Date
2024-03-01
Accepted
2024-03-01 16:13:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 vktx-2024-03-01-424b5.htm 424B5 688717
2 EX-FILING FEES vktx-exfiling_fees.htm EX-FILING FEES 18851
3 GRAPHIC img66375630_0.jpg GRAPHIC 11923
4 GRAPHIC img66375630_1.jpg GRAPHIC 63809
5 GRAPHIC img66375630_2.jpg GRAPHIC 11883
6 GRAPHIC img66375630_3.jpg GRAPHIC 3643
  Complete submission text file 0000950170-24-023848.txt   834802
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273460 | Film No.: 24709871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)